234 results on '"Benfante, Alida"'
Search Results
2. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study
3. Ascending aortic thrombosis in COVID respiratory patient: the "perfect storm"
4. Coronavirus disease 2019 and severe asthma
5. Are nighttime respiratory symptoms assessed by asthma control test affected by comorbidities?
6. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study
7. Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
8. Real-world effectiveness and characteristics of Super-Responders to Mepolizumab and Benralizumab in severe eosinophilic asthma and EGPA
9. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
10. Radiomic features analysis to automatically predict COVID-19 severity outcome by using the LungQuant segmentation software: a multi-center study
11. Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
12. Serum lipoproteins are not associated with the severity of asthma
13. Urinary Incontinence in Chronic Obstructive Pulmonary Disease: A Common Co-morbidity or a Typical Adverse Effect?
14. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
15. Diagnostic and therapeutic approaches for elderly asthma patients: The importance of multidisciplinary and multidimensional management
16. How to unveil chronic respiratory diseases in clinical practice? A model of alliance between general practitioners and pulmonologists
17. Asthma management in a specialist setting: Results of an Italian Respiratory Society survey
18. Impact of Actively Offering Influenza Vaccination to Frail People during Hospitalisation: A Pilot Study in Italy.
19. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
20. Transient asymptomatic bradycardia and remdesivir in COVID-19 patients.
21. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
22. Echocardiographic Evaluation of the Cardiac Chambers in Asthmatic Patients: The BADA (Blood Pressure Levels, Clinical Features and Markers of Subclinical Cardiovascular Damage of Asthma Patients) Study-ECO
23. Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study
24. High-Resolution Computed Tomography for the Evaluation of Airways Distensibility
25. Exhaled nitric oxide is associated with cyclic changes in sexual hormones
26. Serum low density lipoprotein subclasses in asthma
27. Pharmacological Management of Elderly Patients with Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?
28. Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave
29. Comparison between Suspected and Confirmed COVID-19 Respiratory Patients: What Is beyond the PCR Test
30. A 79-year-old-man with SARS-CoV-2 pneumonia and unusual pulmonary co-infection
31. Transient asymptomatic bradycardia and Remdesivir in COVID-19 patients
32. Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis
33. Applicability of the MASK-Air ® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study.
34. The potential role of SP-D as an early biomarker of severity of asthma
35. The impact of SARS-COV2 pandemic on the management oF IPF patients: Our narrative experience
36. Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave
37. Resolution of Chronic Eosinophilic Pneumonia during Treatment with Benralizumab in Patient with Peripheric Blood Eosinophilia
38. PREVALENCE OF ARTERIAL HYPERTENSION AND CHARACTERISTICS OF NOCTURNAL BLOOD PRESSURE PROFILE OF ASTHMA PATIENTS ACCORDING TO THERAPY AND SEVERITY OF THE DISEASE: THE BADA STUDY
39. Severe asthma at COVID-19 time: what is new on biologic therapies
40. Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
41. Severe asthma and COVID-19: lessons from the first wave
42. Fever and dyspnoea in a tracheostomised patient
43. Does the frequency of switching inhalers represent a predictive factor of exacerbation in asthma?
44. Severe asthma and COVID-19: lessons from the first wave.
45. Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis.
46. Does the frequency of switching inhalers represent a predictive factor of exacerbation in asthma?
47. Prevalence of Arterial Hypertension and Characteristics of Nocturnal Blood Pressure Profile of Asthma Patients According to Therapy and Severity of the Disease: The BADA Study
48. The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians
49. Management of suspected COVID-19 patients in a low prevalence region
50. Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.